{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T19:37:34Z","timestamp":1792870654363,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010557","name":"University of South Carolina Office of the Vice President for Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010557","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.schres.2026.10.005","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T10:18:42Z","timestamp":1792750722000},"page":"268-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Emergency department use disparities in schizophrenia: Mediating role of antipsychotic availability and administration"],"prefix":"10.1016","volume":"298","author":[{"given":"Chao","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha M.","family":"Nyame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri Chaitanya Varma","family":"Alluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandana","family":"Chidrala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Fairchild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Lohman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren L.","family":"Wier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Bank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.schres.2026.10.005_bb0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5498\/wjp.v2.i5.74","article-title":"Medication adherence in schizophrenia","volume":"2","author":"Acosta","year":"2012","journal-title":"World journal of psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2026.10.005_bb0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2024.0046","article-title":"Perspectives of Black patients on racism within emergency care","volume":"5","author":"Agarwal","year":"2024","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.schres.2026.10.005_bb0015","author":"AHRQ\/HCUP State Emergency Department Databases"},{"issue":"5","key":"10.1016\/j.schres.2026.10.005_bb0020","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1176\/appi.ps.202000932","article-title":"Variation in psychotropic medication prescription for adults with schizophrenia in the United States","volume":"73","author":"Bareis","year":"2022","journal-title":"Psychiatr. Serv."},{"issue":"4","key":"10.1016\/j.schres.2026.10.005_bb0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.9740\/mhc.2023.08.183","article-title":"Racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using Medicaid claims data","volume":"13","author":"Caballero","year":"2023","journal-title":"Ment. Health Clin."},{"key":"10.1016\/j.schres.2026.10.005_bb0030","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.2147\/PPA.S378951","article-title":"Interventions to improve medication adherence in people with schizophrenia: a systematic review","author":"Cahaya","year":"2022","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.schres.2026.10.005_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2025.116402","article-title":"Latent variable analysis of adherence to antipsychotics among South Carolina medicaid beneficiaries with schizophrenia or schizoaffective disorder","volume":"346","author":"Cai","year":"2025","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.schres.2026.10.005_bb0040","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/schbul\/16.4.571","article-title":"Schizophrenics kill themselves too: a review of risk factors for suicide","volume":"16","author":"Caldwell","year":"1990","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.schres.2026.10.005_bb0045","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/schbul\/sby058","article-title":"Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016","volume":"44","author":"Charlson","year":"2018","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2026.10.005_bb0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41537-023-00334-3","article-title":"Comparison of clinical outcomes in patients with schizophrenia following different long-acting injectable event-driven initiation strategies","volume":"9","author":"Correll","year":"2023","journal-title":"Schizophrenia"},{"issue":"11","key":"10.1016\/j.schres.2026.10.005_bb0055","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.2105\/AJPH.2013.301554","article-title":"Reported racial discrimination, trust in physicians, and medication adherence among inner-city African Americans with hypertension","volume":"103","author":"Cuffee","year":"2013","journal-title":"Am. J. Public Health"},{"issue":"7","key":"10.1016\/j.schres.2026.10.005_bb0060","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jclinepi.2010.10.004","article-title":"A combined comorbidity score predicted mortality in elderly patients better than existing scores","volume":"64","author":"Gagne","year":"2011","journal-title":"J. Clin. Epidemiol."},{"issue":"5","key":"10.1016\/j.schres.2026.10.005_bb0065","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.22m14661","article-title":"Associations of patient race and ethnicity with emergency department disposition for mental health visits in the United States","volume":"84","author":"Gao","year":"2023","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2026.10.005_bb0070","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/JCP.0000000000000523","article-title":"Adherence to antipsychotic medication in bipolar disorder and schizophrenic patients: a systematic review","volume":"36","author":"Garc\u00eda","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2026.10.005_bb0075","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jpsychires.2022.12.044","article-title":"Clinical determinants, patterns and outcomes of antipsychotic medication prescribing in the treatment of schizophrenia and schizoaffective disorder: a naturalistic cohort study","volume":"158","author":"Groenendaal","year":"2023","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.schres.2026.10.005_bb0080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41537-023-00356-x","article-title":"Influencing factors of medication adherence in schizophrenic patients: a meta-analysis","volume":"9","author":"Guo","year":"2023","journal-title":"Schizophrenia"},{"issue":"3","key":"10.1016\/j.schres.2026.10.005_bb0085","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/jamapsychiatry.2020.3995","article-title":"Association between race\/ethnicity and disparities in health care use before first-episode psychosis among privately insured young patients","volume":"78","author":"Heun-Johnson","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2026.10.005_bb0095","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1017\/S0003055411000414","article-title":"Unpacking the black box of causality: learning about causal mechanisms from experimental and observational studies","volume":"105","author":"Imai","year":"2011","journal-title":"Am. Polit. Sci. Rev."},{"key":"10.1016\/j.schres.2026.10.005_bb0090","series-title":"Identification, Inference and Sensitivity Analysis for Causal Mediation Effects","author":"Imai","year":"2010"},{"issue":"10","key":"10.1016\/j.schres.2026.10.005_bb0100","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.63.10.1079","article-title":"Randomized controlled trial of the effect on quality of life of second-vs first-generation antipsychotic drugs in schizophrenia: cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1)","volume":"63","author":"Jones","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2026.10.005_bb0105","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1176\/appi.focus.18402","article-title":"The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia","volume":"18","author":"Keepers","year":"2020","journal-title":"Focus"},{"issue":"1","key":"10.1016\/j.schres.2026.10.005_bb0110","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/1468-0009.12107","article-title":"Race\/ethnicity and overuse of care: a systematic review","volume":"93","author":"Kressin","year":"2015","journal-title":"Milbank Q."},{"issue":"1","key":"10.1016\/j.schres.2026.10.005_bb0115","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1037\/0022-006X.73.1.116","article-title":"Race disparities in psychiatric rates in emergency departments","volume":"73","author":"Kunen","year":"2005","journal-title":"J. Consult. Clin. Psychol."},{"issue":"4","key":"10.1016\/j.schres.2026.10.005_bb0120","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1176\/appi.ajp.159.4.567","article-title":"Racial disparities in antipsychotic prescription patterns for patients with schizophrenia","volume":"159","author":"Kuno","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.schres.2026.10.005_bb0125","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.v63n1007","article-title":"Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature","volume":"63","author":"Lacro","year":"2002","journal-title":"J. Clin. Psychiatry"},{"issue":"11","key":"10.1016\/j.schres.2026.10.005_bb0130","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3111\/13696998.2013.841705","article-title":"Patterns of relapse and associated cost burden in schizophrenia patients receiving atypical antipsychotics","volume":"16","author":"Lafeuille","year":"2013","journal-title":"J. Med. Econ."},{"issue":"4","key":"10.1016\/j.schres.2026.10.005_bb0135","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/104012371502700403","article-title":"Racial differences in antipsychotic use: claims database analysis of Medicaid-insured patients with schizophrenia","volume":"27","author":"Lawson","year":"2015","journal-title":"Ann. Clin. Psychiatry"},{"issue":"12","key":"10.1016\/j.schres.2026.10.005_bb0140","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.schres.2026.10.005_bb0145","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jamapsychiatry.2019.3360","article-title":"Schizophrenia\u2014an overview","volume":"77","author":"McCutcheon","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.10.005_bb0150","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41537-024-00470-4","article-title":"Differences in schizophrenia treatments by race and ethnicity\u2014analysis of electronic health records","volume":"10","author":"Medina","year":"2024","journal-title":"Schizophrenia"},{"key":"10.1016\/j.schres.2026.10.005_bb0155","series-title":"Racism and Psychiatry","author":"Medlock","year":"2018"},{"issue":"4","key":"10.1016\/j.schres.2026.10.005_bb0160","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s40473-021-00236-7","article-title":"Racial disparities in the treatment of schizophrenia spectrum disorders: how far have we come?","volume":"8","author":"Menand","year":"2021","journal-title":"Curr. Behav. Neurosci. Rep."},{"issue":"1","key":"10.1016\/j.schres.2026.10.005_bb0165","doi-asserted-by":"crossref","first-page":"sgae019","DOI":"10.1093\/schizbullopen\/sgae019","article-title":"Racial and ethnic disparities in the diagnosis and early treatment of first-episode psychosis","volume":"5","author":"Moe","year":"2024","journal-title":"Schizophr. Bull. Open"},{"issue":"5","key":"10.1016\/j.schres.2026.10.005_bb0170","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1345\/aph.1C321","article-title":"Role of ethnicity in predicting antipsychotic medication adherence","volume":"37","author":"Opolka","year":"2003","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.schres.2026.10.005_bb0175","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.schres.2023.09.033","article-title":"Racial disparities in utilization of first-generation versus second-generation long-acting injectable antipsychotics in Medicaid beneficiaries with schizophrenia","volume":"261","author":"Pesa","year":"2023","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.schres.2026.10.005_bb0180","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1553-2712.2009.00381.x","article-title":"Racial disparities in emergency department length of stay for admitted patients in the United States","volume":"16","author":"Pines","year":"2009","journal-title":"Acad. Emerg. Med."},{"issue":"4","key":"10.1016\/j.schres.2026.10.005_bb0185","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3371\/CSRP.PORI.050614","article-title":"A pilot study of cultural\/racial differences in patient perspectives on long-acting injectable antipsychotics for the treatment of schizophrenia","volume":"10","author":"Potkin","year":"2017","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"10.1016\/j.schres.2026.10.005_bb0190","series-title":"Health Care Disparities in Emergency Department Visits for Mental Health Disorders","author":"Rahman","year":"2023"},{"issue":"10","key":"10.1016\/j.schres.2026.10.005_bb0195","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/archpsyc.64.10.1123","article-title":"A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?","volume":"64","author":"Saha","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2026.10.005_bb0200","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S2215-0366(17)30233-X","article-title":"Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis","volume":"4","author":"Schoeler","year":"2017","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2026.10.005_bb0205","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/(SICI)1520-6629(199905)27:3<303::AID-JCOP5>3.0.CO;2-9","article-title":"African American service use for mental health problems","volume":"27","author":"Snowden","year":"1999","journal-title":"J. Community Psychol."},{"key":"10.1016\/j.schres.2026.10.005_bb0210","series-title":"South Carolina's Mental Health Landscape: Annual Report","year":"2023"},{"key":"10.1016\/j.schres.2026.10.005_bb0215","author":"State of Mental Health in America"},{"key":"10.1016\/j.schres.2026.10.005_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v059.i05","article-title":"Mediation: R package for causal mediation analysis","volume":"59","author":"Tingley","year":"2014","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.schres.2026.10.005_bb0225","series-title":"VA\/DoD Clinical Practice Guideline for the Management of First-Episode Psychosis and Schizophrenia","author":"U.S. Department of Veterans Affairs and U.S. Department of Defense","year":"2023"},{"key":"10.1016\/j.schres.2026.10.005_bb0230","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.schres.2023.08.024","article-title":"Unraveling ethnic disparities in antipsychotic prescribing among patients with psychosis: a retrospective cohort study based on electronic clinical records","volume":"260","author":"Wang","year":"2023","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2026.10.005_bb0245","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.hrtlng.2011.09.009","article-title":"Medication adherence mediates the relationship between marital status and cardiac event-free survival in patients with heart failure","volume":"41","author":"Wu","year":"2012","journal-title":"Heart Lung"},{"issue":"2","key":"10.1016\/j.schres.2026.10.005_bb0240","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cardfail.2009.10.017","article-title":"Medication adherence is a mediator of the relationship between ethnicity and event-free survival in patients with heart failure","volume":"16","author":"Wu","year":"2010","journal-title":"J. Card. Fail."},{"issue":"1","key":"10.1016\/j.schres.2026.10.005_bb0235","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/JCN.0000000000000427","article-title":"Medication adherence mediates the relationship between heart failure symptoms and cardiac event-free survival in patients with heart failure","volume":"33","author":"Wu","year":"2018","journal-title":"J. Cardiovasc. Nurs."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426003567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426003567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T19:20:24Z","timestamp":1792869624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996426003567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":49,"alternative-id":["S0920996426003567"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2026.10.005","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergency department use disparities in schizophrenia: Mediating role of antipsychotic availability and administration","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2026.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}